1. Meeting the Changing Demands for Sterile-Fill Finish Operations

    Justin Kadis, Business Development for Federal Equipment Company, discusses optimized and error-free fill-finish operations.

  2. Supporting Patient-Centric Clinical Trials from Point-of-Origin through the Last Mile

    Wes Wheeler, CEO of Marken explains how Direct-to-Patient (DTP) clinical trials are becoming an industry standard.

  3. Uniting the Industry for the Prevention of “Pharmageddon”
    Tim Tyson Chairman and CEO of Avara Pharmaceutical Services explains Pharmageddon and how to prevent it.
  4. With Respect to Supplier-Partner Relationships, What is Your Preferred Collaboration Model?
    Experts weigh in on our Roundtable question. 
  5. Reducing Time to Market with Targeted Regulatory Affairs Support

    Regulatory affairs activities are essential components of any drug development and commercialization program, explains Maryse Phan, Head of Regulatory Affairs for API Manufacturing, Servier.

  6. Speeding Development and Reducing Costs with Analytical Quality by Design

    António Ramos, Analytical Chemistry Group Leader, Process Chemistry Development and Rui Loureiro, Director of the R&D Process Chemistry at Hovione outline Quality by Design (QbD) in analytical method development.

  7. Allergan Makes Neurotoxin Buy with Acquisition of Bonti Inc.

    Purchase gives Allergan entry into the market for neurotoxin with cosmetic and medical uses.

  8. J&J Anticipates Growth

    Launches and label extensions are anticipated to drive profits.

  9. Biohaven Reports Positive Results From Double-Blind, Placebo-Controlled, Investigator Initiated, Proof Of Concept Trial Of BHV-0223 For Anxiety

    The company announced positive results from the trial, evaluating the effect of BHV-0223 in patients diagnosed with social anxiety disorder and public speaking anxiety while performing an anxiety-provoking speech task.

  10. Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

    Fasinumab-treated patients experienced significantly less pain and significantly improved functional ability from baseline compared to placebo.

  11. Transforming with an Equipment Partner: Preparing the Industry for Serialization

    Justin Kadis, Business Development for Federal Equipment Company explains the link between the serialization mandate and pharma equipment. 

  12. Leveraging Hot Melt Extrusion for Solubility and Continuous Manufacturing

    Hot melt extrusion (HME) technology has become a key solution to adding absorption for enhanced solubility, says Tony Listro, Vice President, Technical Business Development at Foster Delivery Science.

  13. Experience Meets Flexibility
    Terry Novak, Chief Operating Officer for Tedor Pharma discusses how to meet demands of an increasingly complex global OSD market
  14. Scientific Expertise Facilitates Oral Peptide Product Development and Manufacturing

    Ariana Nagel, Director of Product Development, R&D and and Matthew Ferrell, Director of Analytical Development at UPM Pharmaceuticals explain the benefits and challenges of peptide therapies.

  15. Investing for Successful Advancement of Viral Vector Manufacturing
    Mark Bamforth, CEO and Cofounder and Richard Synder, CSO at Brammer Bio, explain their approach to the latest in gene therapy.
  16. Achieving Successful Treatment Outcomes Through the Delivery of Manufacturing Services
    Janice Graff, Director of Finished Product Sales & Business Development and KaShauna G. Rohlehr PMP, Program Manager at GSK Contract Manufacturing explain the company’s commitment and expertise in the development and commercialization of novel biotherapies.
  17. Preparing for Hurricane Florence in Pharma
    The industry has taken steps to ensure safety in spite of the natural disaster.
  18. Latest Apple Watch Gets FDA Approval as a Class II Device

    The new version of Apple Watch includes an electrocardiogram feature

  19. BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza

    BioNTech will receive $120 million in upfront, equity and near-term research payments from Pfizer and will be eligible to receive up to $305 million in potential development, regulatory and commercial milestone payments and up to double-digit royalties.

  20. Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease

    CEQUA (cyclosporine ophthalmic solution) 0.09% for topical ophthalmic use is the first and only dry eye treatment to combine cyclosporine A with nanomicellar technology.

Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.
SEARCH COMPANIES
Acquisition

Allergan Makes Neurotoxin Buy with Acquisition of Bonti Inc.

Sep 19, 2018 4:15:43 PM PAO-M09-18-NI-015
Investment

J&J Anticipates Growth

Sep 19, 2018 4:07:28 PM PAO-M09-18-NI-014
  • CDMO
  • Pharma

Preparing for Hurricane Florence in Pharma

Sep 18, 2018 3:11:56 PM PAO-M09-18-NI-013
FDA Approval

Latest Apple Watch Gets FDA Approval as a Class II Device

Sep 18, 2018 2:54:20 PM PAO-M09-18-NI-012
Serialization

Transforming with an Equipment Partner: Preparing the Industry for Serialization

Sep 17, 2018 6:00:00 AM PAO-M09-18-CL-001
Annoucement

Novartis Unloads Sandoz US Components

Sep 14, 2018 1:17:21 PM PAO-M09-18-NI-011
IPO

Ophthalmic Drug Developer Kodiak BioSciences Files for IPO

Sep 14, 2018 1:15:11 PM PAO-M09-18-NI-010
Oncology

EU Gives Nod to KEYTRUDA and Chemotherapy Combination Treatment

Sep 14, 2018 1:12:10 PM PAO-M09-18-NI-009
Breakthrough Therapy

Breakthrough Therapy Designation for New Asthma Drug

Sep 13, 2018 2:38:31 PM PAO-M09-18-NI-008
Drug Development

Sanofi-Aventis Collaborates with Dyadic International on Cl Gene Expression

Sep 13, 2018 2:34:36 PM PAO-M09-18-NI-007
Drug Development

Bayer Gets FDA Approval for Hemophilia A Drug

Sep 6, 2018 2:35:00 PM PAO-M09-18-NI-006
Pediatric

Incorrect Dosing Cup Leads to Recall of Children’s Advil Suspension

Sep 6, 2018 2:31:17 PM PAO-M09-18-NI-005
Drug Development

Funding Raised for Development of Drug to Treat Symptoms of Menopause

Sep 6, 2018 2:26:11 PM PAO-M09-18-NI-004
Columns

Nice Insight Overview

Changes in the  Biopharma Industry: from Minor to Major Evolution
New technologies such as gene editing are leading to the development of even more advanced, targeted medicines.

The Next-Generation Player

Addressing Development Challenges for Complex Biologic Drug Candidates
At Lonza, we are constantly looking to reduce the development timeline, giving our customers more control over their projects.


Karen Fallen, Vice President, Business Unit Head of Clinical Development & Manufacturing Lonza Pharma & Biotech

M+A Column

Inside Mergers & Acquisitions
Kevin Bottomley Partner, Results Healthcare
Deals in the pharmaceutical industry are an important mechanism of acquiring innovation, business and efficiency.

Nice Insight Overview

Doping: Famous Cases, Substances and Values in Sports

Marc Technow, Nice Insight